Both classes of agents reduce cardiometabolic risk factors such as HbA1c, body weight, blood pressure and albuminuria, although the effects of GLP-1 receptor agonists on glycemia and body weight are substantially greater than those of SGLT2 inhibitors
p=0.16), and rehospitalization for HF or death (HR 1.36
Why its different
[DOI] [PMC free article] [PubMed] [Google Scholar] 17.Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, et al
Because youre not doing anyone a favor, you may be causing more harm than good. If youre having side effects from GLP-1 or similar drugs, whether youre taking Ozempic, Wegovy, or Mounjaro, a physician can order tests to identify whether the medication is the problem
Moein and continue to be the most humble and kind doctor I know